Losartan Blocks Osteosarcoma Elicited Monocyte Recruitment, and Combined with the Kinase Inhibitor Toceranib, Exerts Clinical Benefit in Canine Metastatic Osteosarcoma

Losartan Blocks Osteosarcoma Elicited Monocyte Recruitment, and Combined with the Kinase Inhibitor Toceranib, Exerts Clinical Benefit in Canine Metastatic Osteosarcoma

Losartan Blocks Osteosarcoma Elicited Monocyte Recruitment, and Combined with the Kinase Inhibitor Toceranib, Exerts Clinical Benefit in Canine Metastatic Osteosarcoma

Daniel P Regan, Lyndah Chow, Sunetra Das, Laurel Haines, Eric Palmer, Jade N Kurihara, Jonathan W Coy, Alissa Mathias, Douglas H Thamm, Daniel L Gustafson, Steven W Dow

Clinical Cancer Research 28(4):clincanres.2105.2021